CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This research study involves pre-operative therapy that is specifically targeted for breast cancer in individuals with BRCA and PAL...
Phase 2
Baltimore, Maryland, United States and 8 other locations
radiation treatment after undergoing a lumpectomy, also known as "breast conserving surgery". In this trial, we are attempting to identify w...
Phase 2
Baltimore, Maryland, United States and 5 other locations
This research study is for patients with metastatic breast cancer.* Metastatic means that the cancer has spread beyond the ...
Phase 2
Baltimore, Maryland, United States and 19 other locations
This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...
Phase 1, Phase 2
Washington, District of Columbia, United States and 1 other location
triple negative (TN) or hormone receptor positive/HER2-negative breast cancer.The names of the study interventions involved in this...
Phase 2
Baltimore, Maryland, United States and 9 other locations
Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...
Phase 3
Bethesda, Maryland, United States and 13 other locations
This study is being done to look at the role of continuing palbociclib treatment in combination with another type of hormonal therapy (fulvestrant) a...
Phase 2
Baltimore, Maryland, United States and 4 other locations
This research is being done to determine if early changes on a type of imaging procedure called PET (Positron Emission Tomography) can predict which...
Phase 2
Baltimore, Maryland, United States and 9 other locations
A phase 1b study to assess the combination of ARV-471 and everolimus in participants with advanced or metastatic ER+/HER2- breast cancer...
Phase 1
Washington, District of Columbia, United States and 8 other locations
This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast...
Phase 2
Washington, District of Columbia, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal